The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Cambridge-based biopharmaceutical company Sage Therapeutics filed a lawsuit against their partner, the biotechnology company ...

A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their ...

Sutro Biopharma Inc. (NASDAQ:STRO) shares have tumbled to a 52-week low, touching down at $1.67, as the biopharmaceutical company grapples with a challenging market environment. With a market ...

We recently published a list of 10 Best Nasdaq Stocks Under $5 to Buy. In this article, we are going to take a look at where Arbutus Biopharma Corp. (NASDAQ:ABUS) stands against other best Nasdaq ...

Janney Montgomery Scott LLC increased its position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) by 31.4% during the 4th quarter, according to its most recent filing with the ...

Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the company, Marketbeat reports. One analyst ...

U.S. Rep. April McClain Delaney visited Kite, a biopharmaceutical company that uses cell therapy to treat cancer, in Urbana on Thursday morning, one of several locations across her district she ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by US Federal Reserve interest rate cuts, Medicare policy concerns over President ...